Multiomics Analysis Reveals Microbiota, Immune and Metabolomics Characteristics in COVID-19 Patients with Differing Severity
Open Access
- 30 July 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Infectious Microbes and Diseases
- Vol. 8 (3) , 175-186
Abstract
Background & aims: The COVID-19 pandemic remains a significant clinical challenge compounded by the emergence of new variants with heightened pathogenicity. This study aimed to characterize multiomics alterations in COVID-19 patients and establish an early predictive model for disease progression. Methods: We analyzed the oral and gut microbiomes, serum metabolome and immune cell profiles in 35 healthy controls and 101 COVID-19 patients with varying severity. Results: COVID-19 patients showed significant reductions in oral and gut microbial diversity, with depletion of beneficial butyrate-producing bacteria and enrichment of opportunistic pathogens like Enterococcus and Streptococcaceae. While overall microbial community structures between severity groups were similar, specific taxonomic and functional shifts were evident, such as an enrichment of oral Helicobacter ganmani and a depletion of gut Gordonibacter pamelaeae in the severe group. Serum metabolomics revealed distinct profiles, with altered lysine degradation in severe cases. Crucially, immune phenotyping demonstrated that severely ill patients had a significantly lower frequency of CD4 + PD-1 + CD69 − T cells, a subset critical for early immune homeostasis, early in the infection. In addition, a preliminary integrated predictive model integrating age, CD4 + PD-1 + CD69 − T cells and oral H. ganmani demonstrated superior discriminatory power for predicting nonsevere COVID-19 cases in the early stage with a risk of progressing to the severe stage. Conclusions: These findings highlight the critical role of early immune dysregulation and suggest that a combined microbial and immune marker approach holds significant potential for timely risk stratification in COVID-19.Keywords
This publication has 33 references indexed in Scilit:
- Oral SARS‐CoV‐2 Infection and Risk for Long CovidReviews in Medical Virology, 2025
- Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19Nature Communications, 2023
- Distinct gut microbiota and health outcomes in asymptomatic infection, viral nucleic acid test re‐positive, and convalescent COVID‐19 casesmLife, 2022
- Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19Signal Transduction and Targeted Therapy, 2021
- PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19Immunity, 2021
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumoniaNature Communications, 2020
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosaInternational Journal of Oral Science, 2020
- DADA2: High-resolution sample inference from Illumina amplicon dataNature Methods, 2016
- Protein selection and export via outer membrane vesiclesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014